Clinical Effect of Mirikizumab Treatment on Bowel Urgency in Patients with Moderately to Severely Active Ulcerative Colitis and the Clinical Relevance of Bowel Urgency Improvement for Disease Remission.

MLA

Dubinsky, Marla C., et al. “Clinical Effect of Mirikizumab Treatment on Bowel Urgency in Patients with Moderately to Severely Active Ulcerative Colitis and the Clinical Relevance of Bowel Urgency Improvement for Disease Remission.” Crohn’s & Colitis 360, vol. 5, no. 1, Jan. 2023, pp. 1–13. EBSCOhost, https://doi.org/10.1093/crocol/otac044.

APA

Dubinsky, M. C., Clemow, D. B., Gibble, T. H., Xingyuan Li, Vermeire, S., Tadakazu Hisamatsu, & Travis, S. P. L. (2023). Clinical Effect of Mirikizumab Treatment on Bowel Urgency in Patients with Moderately to Severely Active Ulcerative Colitis and the Clinical Relevance of Bowel Urgency Improvement for Disease Remission. Crohn’s & Colitis 360, 5(1), 1–13. https://doi.org/10.1093/crocol/otac044

Chicago

Dubinsky, Marla C., David B. Clemow, Theresa Hunter Gibble, Xingyuan Li, Severine Vermeire, Tadakazu Hisamatsu, and Simon P. L. Travis. 2023. “Clinical Effect of Mirikizumab Treatment on Bowel Urgency in Patients with Moderately to Severely Active Ulcerative Colitis and the Clinical Relevance of Bowel Urgency Improvement for Disease Remission.” Crohn’s & Colitis 360 5 (1): 1–13. doi:10.1093/crocol/otac044.